濮阳东方医院看妇科病收费比较低(濮阳东方医院收费咨询) (今日更新中)

The Flores family has been farming dates for three generations.For the past few years, Marco Flores, owner of San Marcos Date Farm, says he’s seen major changes in temperature and weather patterns.“It’s drier than it used to be,” he said of the land his father bought in California’s Coachella Valley more than 55 years ago. “It used to be a lot more moist before.”These are conditions his 300 fruit-producing palm trees don’t like.“Sometimes there’s no rain,” Flores said. “The impact of climate change is definitely doing something to them.”Similar concerns are being expressed across the planet.“Climate change is impacting agriculture and farmers abilities,” said Paul Minehart of the Syngenta Group, a global agricultural innovation company.Minehart’s team recently published a study showing 72% of farmers they interviewed from around the world are worried about climate changes impacting crop yields.“It’s coming down to, especially in the United States, is the unpredictable weather patterns that are beginning to emerge,” he said.Minehart says those unpredictable weather patterns include unusual droughts and flooding in America and extremely arid conditions in other countries. Conditions that could impact farmers production and profits.“If you have fewer crops than the price could go up,” he said. “That could impact the overall cost of producing food and then at the consumer level buying the food.”Marco Juarez is the third generation of Flores farmers at San Marcos Date Farm.He says while using more water could cause his family to raise their prices from a pound for dates, there’s another growing concern: getting skilled workers to take a job in this heat.“I don’t think anyone really wants to work in this,” he said. “It slowly drives people away. I mean, who wants to be here in 120 degrees?” 1826

The coronavirus pandemic may have started earlier than previously thought, according to scientists from the CDC.A study from government scientists published November 30 appears to confirm what some health experts have suggested, patients infected with COVID-19 were in the US before the beginning of 2020.“The findings of this report suggest that SARS-CoV-2 infections may have been present in the U.S. in December 2019, earlier than previously recognized. These findings also highlight the value of blood donations as a source for conducting SARS-CoV-2 surveillance studies,” the report states.The first officially documented case of COVID-19 in the US was reported on January 19, a person who had returned to the US after traveling from China.The World Health Organization was alerted to the novel coronavirus by officials in Wuhan, China on December 31, 2019. The CDC researchers say further reports have identified a patient in Wuhan with COVID-19 symptoms as early as December 1, 2019.The study looked at more than 7,000 routine blood donation samples taken by the American Red Cross from people in nine states between December 13, 2019 and January 17, 2020.They found COVID-19 antibodies in 106 samples, mostly from the states of California, Oregon and Washington, from blood collected between December 13-16, 2019. Other samples that indicated COVID-19 antibodies were from Connecticut, Iowa, Massachusetts, Michigan, Rhode Island, and Wisconsin taken in early January 2020.“The presence of these serum antibodies indicate that isolated SARS-CoV-2 infections may have occurred in the western portion of the United States earlier than previously recognized or that a small portion of the population may have pre-existing antibodies that bind SARS-CoV-2,” the report states.Scientists acknowledge that patients presenting with what is now known as COVID-19 symptoms before mid-January would likely not have had clinical samples taken or kept because of how new the virus was. Therefore, the CDC used the existing repository collected by the American Red Cross during their routine blood donation process.“These specimens were previously archived for potential future studies to identify emerging transfusion-transmissible infections but were re-purposed for the present study,” researchers stated.Researchers caution that these results are subject to limitations. Although they detected antibodies, that does not mean they are “true positive” COVID-19 tests. In order to get a true positive, a different test would need to be a run. 2545

The Geminid meteor shower peaks this week, so hope for clear skies that will let you see a beautiful show of green fireballs on Thursday and Friday. This will be the last -- and strongest -- meteor shower of the year, according to NASA.This phenomenon was first recorded in 1862 and causes a show each December.In the hours before sunrise Friday, the most meteors will be visible in the North American sky, peaking about 7:30 a.m. ET, predicts Sky & Telescope. To see when they will peak in your part of the world, check here.But the morning isn't your only chance. On Thursday and Friday, keep an eye on the sky a few hours after sunset -- just keep the moon at your back.Although the Geminid shower is known for its "shooting stars," the number of meteors visible depends on the time and how dark it is. There will be fewer of them earlier in the evening, but the shower should hit a maximum of about 100 per hour around 2 a.m., NASA said. For those in the suburbs, expect about 30 to 40 per hour. And if you're in a city like New York, San Francisco or Atlanta, you probably won't see anything.Early evening meteors may be longer, with dramatic streaks that last several seconds. Later on, the meteors will present quicker streaks or leave trails of smoke that appear to glow.The asteroid 3200 Phaethon is responsible for this meteor shower, which is unusual because comets usually create meteor showers with icy debris. Scientists have debated the very nature of what Phaethon is. The closely tracked near-Earth asteroid has been likened to comets, so it's been called a "rock comet."Phaethon was discovered in October 1983 and named after the Greek myth about the son of Helios, the sun god, because it closely approaches our sun.Phaethon orbits the sun closer than any other asteroid and takes 1.4 years to orbit it. The asteroid heats to about 1,300 degrees Fahrenheit on closest approach to the sun, which causes it to shed dusty debris.These particles cause the meteor shower when they plunge into Earth's atmosphere at 22 miles per second, vaporizing in the streaks we call "shooting stars."If you live in an urban area, you may want to drive to a place that isn't littered with city lights that will obstruct your view. If you're able to find an area unaffected by light pollution, meteors could be visible every couple of minutes from 10 p.m. until dawn.Find an open area with a wide view of the sky, and don't forget to bundle up. Make sure you have a chair or blanket so you can look straight up. And give your eyes about 20 to 30 minutes to adjust to the darkness -- without looking at your phone -- so meteors are easier to spot.While you're keeping an eye out for the meteor shower, you might see a small, foggy green patch in the sky, NASA said. That will be Comet 46P/Wirtanen, which is making its closest approach to Earth -- within 7 million miles -- for the next 20 years. And it will be visible to the naked eye. The comet is expected to come closest to Earth and peak Sunday. 3007

The digital news company Mic has laid off most of its staff, a spokesperson for the company confirmed.The layoffs were first reported Thursday by Recode. It is not yet clear exactly how many employees were affected. Mic declined to comment beyond confirming the Recode report.The company was founded in 2011, and for the past several years has branded itself as a news website geared toward millennials.Mic Publisher Cory Haik also resigned Thursday. In a note to staff that was obtained by CNN Business, Haik called journalism a "tough business.""Our business models are unsettled, and the macro forces at play are all going through their own states of unrest," she wrote. "If anyone tells you they have it figured out, a special plan to save us all, or that it's all due to a singular fault, know that is categorically false. Like the truth, it is indeed complicated."Mic was once a digital media darling, attracting around million in funding from investors. Its biggest backers included Lightspeed Venture Partners, Clark Jermoluk Founders Fund, WPP and WarnerMedia. (WarnerMedia owns CNN.)The company's staff swelled to more than 100 people by early 2016, according to The New York Times, which asked in an article published at the time: "What happens when millennials run the workplace?"But the climate is a tough one for digital media publishers right now. Ad revenue alone hasn't been enough to support these businesses, and Google and Facebook have substantial control over the ad market.Refinery29, HuffPost and Vocativ have all cut staff in the past year. So have CNN Digital, Vice and BuzzFeed.Mic laid off 25 employees in August 2017 as part of a pivot to video. Co-founder and CEO Chris Altchek told staff at the time that the shift was needed because "visual journalism already makes up 75% of the time that our audience spends" with the site.There were signs this year that the environment wasn't improving for Mic. Digiday reported in April that traffic to Mic's website had been plunging.The article also noted that Mic was very reliant on Facebook, citing statistics that showed views on the social media site fell to 11 million views in March compared to 192 million about a year earlier.Still, company executives pushed back on some reports that characterized the situation at Mic as particularly dire. When the Columbia Journalism Review reported in September that the company's board discussed a possible shutdown, Altchek called the report "categorically false."Emily Singer, a senior political reporter at Mic, tweeted Thursday that she was leaving the company."I'm so proud of what we've accomplished here," Singer wrote.Kerry Lauerman, Mic's executive news director, tweeted about the "gutting experience" Thursday."But only love for the extremely resilient and open-hearted team of Mic editors, producers, writers and shooters I had the great honor of working with," he added. "They performed brilliantly often under a cloud of uncertainty."Reached by phone, Lauerman declined to comment further, saying only that the team was packing up all of their things.Several other employees also tweeted news of their departures."I have so much to say, but most importantly the time I spent at @mic was the best of my career," wrote Managing Editor Colleen Curry. "I learned so, so much from brilliant people dedicated to keeping journalism alive."Mic is also in talks to sell at least part of the company to Bustle Digital Group, Recode reported Wednesday. A source with knowledge of the potential deal confirmed that report to CNN Business. 3572

The Food and Drug Administration approved on Wednesday a treatment for the Ebola virus. This is the first FDA-approved treatment for Zaire ebolavirus infection in adults and kids.Zaire ebolavirus is one of four Ebola virus species that can cause potentially deadly infections. It is transmitted through direct contact with blood, tissue or body fluids of an infected person or wild animal.The treatment, Inmazeb, is a mixture of three monoclonal antibodies and was created by Regeneron Pharmaceuticals. The three antibodies work together to bind to the glycoprotein on the surface of the Ebola virus and block it from entry into the body’s cells.Inmazeb was tested in the Democratic Republic of the Congo during an Ebola virus outbreak in 2018-2019 through a partnership between the local government and the National Institutes of Health.A vaccine for Ebola virus was approved by the FDA in December 2019.Regeneron is also the company behind an experimental antibody cocktail that was given to President Donald Trump following his diagnosis of COVID-19, and which he said “cured” him. Trump was also prescribed the antiviral drug remdesivir and the steroid dexamethasone at the time.Regeneron’s COVID-19 treatment is a mix of two powerful antibodies that are believed to boost the immune response to the coronavirus. Early results seem promising, according to initial tests and a press release from the company.The company has submitted an application to the FDA to get emergency approval of their COVID-19 treatment. 1525

来源：资阳报